First Time Loading...

Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 626 JPY -0.61%
Updated: Mar 29, 2024

Intrinsic Value

Fuji Pharma Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. [ Read More ]

The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 449.16 JPY. Compared to the current market price of 1 626 JPY, Fuji Pharma Co Ltd is Undervalued by 34%.

Key Points:
Intrinsic Value
Base Case
2 449.16 JPY
Undervaluation 34%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Fuji Pharma Co Ltd

Backtest Fuji Pharma Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Fuji Pharma Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Fuji Pharma Co Ltd's business.

What risks and challenges
does Fuji Pharma Co Ltd face in the near future?

Summarize the latest earnings report
of Fuji Pharma Co Ltd.

Provide P/E
for Fuji Pharma Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
Fuji Pharma Co Ltd

Current Assets 40.4B
Cash & Short-Term Investments 2.2B
Receivables 16.7B
Other Current Assets 21.5B
Non-Current Assets 44.2B
Long-Term Investments 6.1B
PP&E 21.2B
Intangibles 10.3B
Other Non-Current Assets 6.5B
Current Liabilities 27.7B
Accounts Payable 6.8B
Accrued Liabilities 264m
Short-Term Debt 11.3B
Other Current Liabilities 9.4B
Non-Current Liabilities 14.9B
Long-Term Debt 12.4B
Other Non-Current Liabilities 2.5B
Efficiency

Earnings Waterfall
Fuji Pharma Co Ltd

Revenue
41.6B JPY
Cost of Revenue
-25.6B JPY
Gross Profit
16B JPY
Operating Expenses
-13.5B JPY
Operating Income
2.5B JPY
Other Expenses
2.5B JPY
Net Income
5.1B JPY

Free Cash Flow Analysis
Fuji Pharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Fuji Pharma Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
ROE is Increasing
Positive 3-Years Revenue Growth
49/100
Profitability
Score

Fuji Pharma Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Fuji Pharma Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

Fuji Pharma Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Fuji Pharma Co Ltd

Wall Street analysts forecast Fuji Pharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Fuji Pharma Co Ltd is 2 132.31 JPY with a low forecast of 2 000.81 JPY and a high forecast of 2 310 JPY.

Lowest
Price Target
2 000.81 JPY
23% Upside
Average
Price Target
2 132.31 JPY
31% Upside
Highest
Price Target
2 310 JPY
42% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Fuji Pharma Co Ltd

1M 1M
-7%
6M 6M
+39%
1Y 1Y
+48%
3Y 3Y
+32%
5Y 5Y
+4%
10Y 10Y
+95%
Annual Price Range
1 626
52w Low
1 096
52w High
2 020
Price Metrics
Average Annual Return -10.66%
Standard Deviation of Annual Returns 10.56%
Max Drawdown -49%
Shares Statistics
Market Capitalization 39.5B JPY
Shares Outstanding 24 305 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

39.5B JPY

Dividend Yield

2.75%

Description

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Contact

TOKYO-TO
Chiyoda-ku
6F, Seito Kaikan, 5-7, Samban-cho
+81335563344.0
http://www.fujipharma.jp/

IPO

1995-06-22

Employees

1 532

Officers

President & CEO
Mr. Takayuki Iwai
VP, Executive Officer & Director
Mr. Toyoyuki Kamide
Managing Executive Officer & GM of Corporate Division
Mr. Seiichi Inoue
Managing Executive Officer
Takeshi Sato

See Also

Discover More
What is the Intrinsic Value of one Fuji Pharma Co Ltd stock?

The intrinsic value of one Fuji Pharma Co Ltd stock under the Base Case scenario is 2 449.16 JPY.

Is Fuji Pharma Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 626 JPY, Fuji Pharma Co Ltd is Undervalued by 34%.